Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate Cancer
Clinical trial NCT06029088 · COMPLETED
Trial details
- NCT number
- NCT06029088
- Sponsor
- Ankara Etlik City Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-12
- Primary completion
- 2023-05-21
- Enrollment
- 616
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.